21 Mai 2026

INSIGHT 2026 – Rethinking Dissolution Automation

Discover how leading pharma organizations are approaching dissolution automation within a broader landscape of innovation in R&D and QC, and delve deeply into modern dissolution science, from methodology and modeling to complex applications.

As laboratories strive for higher efficiency, consistency, and data quality, automation in dissolution is moving from a future vision to a strategic priority – across both R&D and Quality Control.

INSIGHT 2026, the new pharmaceutical conference by SOTAX, provides a unique opportunity to explore this topic through real-world experience from industry peers.

Rather than relying on theory, you will gain direct insights from experts who are already working with advanced automation systems – sharing what works, what doesn’t, and what truly delivers value. Interactive elements such as hands-on workshops allow you to go beyond presentations – bringing real applications, challenges, and solutions to life.

The automation of dissolution testing is just one of the topics covered at INSIGHT 2026. The conference itself offers a much broader perspective on the future of pharmaceutical testing:
 

• Advanced dissolution science & method development

• Predictive & model-based development

• Release testing of complex dosage forms

• Innovative automated sample preparation

• Digital transformation and connected laboratory environments
   

If you are currently evaluating automation in dissolution testing, this is your opportunity to gain clarity – from real users, real applications, and real results.

Register now for INSIGHT 2026
Dublin, 07 – 08 October 2026
www.insight2026.com